Back

HFpEF management: state of the art novel devices.

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: How-To manage HFpEF: state of the art in 2021 Chronic Heart Failure ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor David Kaye

Baker Heart and Diabetes Institute, Melbourne (Australia)

4 More presentations in this session

Presentation thumbnail
HFpEF management: state of the art neurohumoral modulation.
Professor S. Solomon (Boston, US)
Slides Video
Presentation thumbnail
HFpEF management: state of the art SGLT2 inhibitors.
Professor R. De Boer (Rotterdam, NL)
Video
Presentation thumbnail
How-To manage HFpEF: state of the art in 2021 – discussion.
Presentation thumbnail
How-To manage HFpEF: state of the art in 2021 - Chat Moderator.

Access the full session

Session thumbnail
How-To manage HFpEF: state of the art in 2021
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Presentation
Presence of heart failure in pts with coronary artery disease and artery hypertension
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources